150
Participants
Start Date
November 30, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
Salmeterol/fluticasone propionate combination
GSK Investigational Site, Liège
GSK Investigational Site, Ghent
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Madrid
GSK Investigational Site, Tampere
GSK Investigational Site, Montpellier
GSK Investigational Site, Bussolengo (VR)
GSK Investigational Site, Jyväskylä
GSK Investigational Site, Valencia
GSK Investigational Site, Tartu
GSK Investigational Site, Bonn
GSK Investigational Site, Pisa
GSK Investigational Site, Lille
GSK Investigational Site, Torrette (AN)
GSK Investigational Site, Foggia
GSK Investigational Site, Sinsheim
GSK Investigational Site, Salerno
GSK Investigational Site, Poitiers
GSK Investigational Site, Cagliari
GSK Investigational Site, Riga
GSK Investigational Site, Riga
GSK Investigational Site, Breda
GSK Investigational Site, Groningen
GSK Investigational Site, Harderwijk
GSK Investigational Site, Helmond
GSK Investigational Site, Hoorn
GSK Investigational Site, Nieuwegein
GSK Investigational Site, Veldhoven
GSK Investigational Site, Barcelona
GSK Investigational Site, Tarrasa, Barcelona
GSK Investigational Site, Gothenburg
GSK Investigational Site, Linköping
GSK Investigational Site, Lund
Lead Sponsor
GlaxoSmithKline
INDUSTRY